Nusinersen therapy changed the natural course of spinal muscular atrophy type 1: What about spine and hip?
Niyazi Erdem Yaşar(Ministry of Health), Şenol Bekmez(Ministry of Health), Naim Ata(Ministry of Health), Şuayıp Birinci(Ministry of Health), Güzelali Özdemir(Sağlık Bilimleri Üniversitesi), Mustafa Mahir Ülgü(Ministry of Health), İzzet Bingöl(Ankara Onkoloji Eğitim ve Araştırma Hastanesi), Ebru Dumlupınar(Ankara University), Elif Uzun Ata(Bilkent University), Mustafa Okan Ayvalı(Ministry of Health)
Cited by 16
Related Papers
The outcome of COVID‐19 in patients with hematological malignancy
|Journal of Medical Virology|2020|134
Cesarean section rates in Turkey 2018-2023: Overview of national data by using Robson ten group classification system
|Journal of Turkish Society of Obstetric and Gynecology|2023|41
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
|Journal of Oncology Pharmacy Practice|2020|40
Adoption rates of electronic health records in Turkish Hospitals and the relation with hospital sizes
|BMC Health Services Research|2020|40
Older Adults With Coronavirus Disease 2019: A Nationwide Study in Turkey
|The Journals of Gerontology Series A|2020|34